We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A group of medical officials in Washington state has created a proposal that suggests a maximum daily dosage of narcotic painkillers in an attempt to prevent accidental deaths from overdose.
The Department of Justice (DOJ) has entered into another multi-million dollar off-label promotion settlement, which sources say reflects an enforcement priority for the federal government.
A coalition of drug wholesalers will soon seek an injunction in federal court to delay the implementation of the FDA’s long-awaited drug tracking program, contending the new requirement will devastate their businesses.
Bristol-Myers Squibb’s (BMS) problems continue as the company lost substantial revenue from generic competition to its blood thinner Plavix and now faces potentially broader criminal charges related to the drug.
The FDA’s decision to perform 45 Class I recalls over the past year signals a fundamental shift in enforcement policy for an agency still reeling from criticism over recent drug safety incidents, sources say.
Bristol-Myers Squibb’s (BMS) problems continue as the company lost substantial revenue from generic competition to its blood thinner Plavix and now faces potentially broader criminal charges related to the drug.
The FDA’s decision to perform 45 Class I recalls over the past year signals a fundamental shift in enforcement policy for an agency still reeling from criticism over recent drug safety incidents, sources say.
The Centers for Medicare & Medicaid Services (CMS) is using a proposed rule issued Oct. 18 to test the legal waters for its plan to collect and share prescription drug plan data so it can base Medicare reimbursements on product comparisons, sources say.
Eli Lilly developed fraudulent practice guidelines based on limited data, input from researchers with financial conflicts and the work of industry front groups to increase sales of its sepsis treatment Xigris, according to three NIH investigators.